Target intelligence / Profile preview

Mycobacterial 50S ribosomal subunit, peptidyl-tRNA site (P-site) (50S P-site)

Target
50S P-site
Molecular classification
Ribonucleoprotein, Ribosome, Bacterial translation machinery
01

Overview

The Mycobacterial 50S ribosomal subunit, P-site (peptidyl-tRNA site) is a vital functional domain within the large subunit of the ribosome in mycobacterial species, including Mycobacterium tuberculosis. Its primary biological role is to accommodate the tRNA molecule attached to the nascent polypeptide chain, facilitating the peptidyl transferase reaction and subsequent translocation during protein synthesis (Wilson, 2014, PubMed). This site is the primary target for the oxazolidinone class of antibiotics, such as linezolid and tedizolid, which bind to the 23S rRNA at the peptidyl transferase center (PTC) to inhibit the formation of the 70S initiation complex (Hentschel et al., 2017, Nature). By disrupting the translation process, these drugs exert a bacteriostatic or bactericidal effect, making the P-site a cornerstone in the treatment of multi-drug resistant tuberculosis (MDR-TB). However, because the P-site shares structural similarities with the human mitochondrial ribosome, prolonged use of drugs targeting this site can lead to mitochondrial dysfunction and associated toxicities like myelosuppression and neuropathy (StatPearls, 2023). Resistance to P-site inhibitors often involves point mutations in the 23S rRNA or enzymatic modification by methyltransferases, which reduce drug binding affinity (NCBI, 2022).

Other names
Peptidyl-site of the 50S ribosomeMycobacterial 50S P-site23S rRNA P-siteMycobacterial large ribosomal subunit P-sitePeptidyl transferase center P-site
02

Mechanism of action

Inhibition of protein synthesis by binding to the P-site and adjacent peptidyl transferase center of the 50S ribosomal subunit, thereby preventing the formation of the functional 70S initiation complex and interfering with the translocation of peptidyl-tRNA (Wilson, 2014, PubMed).

03

Biological functions

Protein synthesisTranslation elongationPeptidyl transferTranslation initiation
04

Disease associations

InfectionTuberculosisNontuberculous mycobacterial infectionLeprosy
05

Safety considerations

Myelosuppression (thrombocytopenia, anemia, leukopenia)Peripheral neuropathyOptic neuropathySerotonin syndromeLactic acidosisMitochondrial toxicity
06

Interacting drugs

Linezolid

5 more in the full profile.

07

Biomarkers

23S rRNA mutations (e.g., G2061V, G2576T)rplC mutations (e.g., T460C)Sputum culture conversionC-reactive protein (CRP) levels

Beyond the preview

Go deeper on Mycobacterial 50S ribosomal subunit, peptidyl-tRNA site (P-site) (50S P-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial 50S ribosomal subunit, peptidyl-tRNA site (P-site) (50S P-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call